Perchlorate

Perchlorate

SCHEMBL4655875

CN(C)c1ccc(C(=C2C=CC(=[N+](C)C)C=C2)c2ccncc2)cc1.[O-][Cl+3]([O-])([O-])[O-]

nearest known ligand 0.76

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.76
TDP1 Q9NUW8 5/20 0.76
MEN1 O00255 5/20 0.76
KMT2A Q03164 5/20 0.76
SMN1; SMN2 Q16637 5/20 0.76
THRB P10828 4/20 0.76
MAPK1 P28482 4/20 0.76
HIF1A Q16665 3/20 0.76
HTT P42858 3/20 0.76
TP53 P04637 3/20 0.76
CYP3A4 P08684 3/20 0.76
ALOX12 P18054 2/20 0.76
RECQL P46063 2/20 0.76
BLM P54132 2/20 0.76
CYP2D6 P10635 2/20 0.76
CHRM5 P08912 2/20 0.76
KDM4E B2RXH2 2/20 0.76
HDAC6 Q9UBN7 2/20 0.76
USP2 O75604 1/20 0.76
EGFR P00533 1/20 0.76

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Perchlorate SCHEMBL4657954 0.99 MAPT (0.74) MAPTTDP1MEN1KMT2ASMN1; SMN2
SCHEMBL4655638 0.94 MAPT (0.85) MAPTTDP1MEN1KMT2ASMN1; SMN2
Hexamethyl Pararosaniline SCHEMBL9171 0.87 TDP1 (1.00) MAPTTDP1MEN1KMT2ASMN1; SMN2
Perchlorate SCHEMBL4655673 0.86 KMT2A (0.67) MAPTTDP1MEN1KMT2ASMN1; SMN2
Hexamethyl Pararosaniline SCHEMBL94116 0.85 TDP1 (0.96) MAPTTDP1MEN1KMT2ASMN1; SMN2
Brilliant Green SCHEMBL28216 0.81 TDP1 (0.88) MAPTTDP1MEN1KMT2ASMN1; SMN2
Perchlorate SCHEMBL4655731 0.81 MEN1 (0.63) MAPTTDP1MEN1KMT2ASMN1; SMN2
Perchlorate SCHEMBL4658062 0.81 TDP1 (0.66) MAPTTDP1MEN1KMT2ASMN1; SMN2
SCHEMBL4655651 0.80 KMT2A (0.74) MAPTTDP1MEN1KMT2ASMN1; SMN2
Brilliant Green SCHEMBL171205 0.80 TDP1 (0.84) MAPTTDP1MEN1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1435227-B1 Composition for the dyeing of keratinous fibres comprising a direct dye of the monoheteroyldiarylmethane type or a leuco precursor thereof and a dyeing process using it OREAL (FR) 2008-12-03 EP claimed
US-7211117-B2 Composition for dyeing keratin fibers comprising at least one dye chosen from monoheteroyldiarylmethane direct dyes and the leuco precursors thereof and dyeing method using it L'OREAL S.A. (FR) 2007-05-01 US claimed
US-20040216247-A1 Composition for dyeing keratin fibers comprising at least one dye chosen from monoheteroyldiarylmethane direct dyes and the leuco precursors thereof and dyeing method using it L'OREAL S.A. (FR) 2004-11-04 US claimed
EP-1435227-A1 Composition for the dyeing of keratinous fibres comprising a direct colourant ofthe monoheteroyldiarylmethane type of a leuco precursor thereof and a dyeing process using it L'OREAL (FR) 2004-07-07 EP claimed
US-7211117-B2 Composition for dyeing keratin fibers comprising at least one dye chosen from monoheteroyldiarylmethane direct dyes and the leuco precursors thereof and dyeing method using it L'OREAL S.A. (FR) 2007-05-01 US disclosed
US-20040216247-A1 Composition for dyeing keratin fibers comprising at least one dye chosen from monoheteroyldiarylmethane direct dyes and the leuco precursors thereof and dyeing method using it L'OREAL S.A. (FR) 2004-11-04 US disclosed
EP-1435227-A1 Composition for the dyeing of keratinous fibres comprising a direct colourant ofthe monoheteroyldiarylmethane type of a leuco precursor thereof and a dyeing process using it L'OREAL (FR) 2004-07-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040216247-A1 Composition for dyeing keratin fibers comprising at least one dye chosen from monoheteroyldiarylmethane direct dyes and the leuco precursors thereof and dyeing method using it KRT18, KMO, PLOD3 MAPT 600/4885TDP1 2771/4885MEN1 4140/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.